1. Thailand Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Bumrungrad Hospital Public Company Limited

Bumrungrad Hospital Public Company Limited

BUGDF
Bumrungrad Hospital Public Company LimitedUS flagOther OTC
4.75
USD
- -
- -
3.78BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
19.69
21.45
24.24
24.59
24.82
25.15
25.35
15.82
15.68
26.07
31.92
32.35
- -
30.89
Basic EPS, GAAP
3.46
3.75
4.72
4.98
5.41
5.7
5.14
1.54
1.53
6.21
8.81
9.78
- -
9.24
Free Cash Flow per Basic Share
1.43
3.61
3.36
3.73
4.91
5.27
4.13
1.62
3.26
6.28
6.82
9.25
- -
5.85
Dividend per Share
1.9
1.9
2.15
2.4
2.55
2.8
2.95
3.25
3.2
3.2
3.7
5.16
- -
4.85
Book Value per Share
11.56
13.34
15.82
18.37
21.13
24.04
26.47
22.95
20.95
24.09
29.18
33.8
- -
39.14
Tangible Book Value per Share
12.91
15.1
17.59
19.69
22.08
24.53
26.65
23.1
21.18
24.28
29.47
34.16
- -
39.33
Basic Weighted Avg Shares
729
729
729
729
729
729
729
782
795
795
795
795
- -
819
Sales/Revenue/Turnover
14,346
15,630
17,660
17,915
18,087
18,326
18,474
12,362
12,460
20,721
25,376
25,718
25,215
25,298
Operating Margin (%)
21.47
21.91
24.01
24.87
26.73
27.73
24.48
11.07
12.66
29.01
33.39
35.73
36.07
36.29
Depreciation Expense
882
1,045
1,045
1,139
1,206
1,180
1,223
1,220
1,180
1,117
1,097
1,077
1,068
1,094
Net Income, GAAP
2,521
2,730
3,436
3,626
3,944
4,152
3,748
1,204
1,216
4,938
7,006
7,775
7,512
7,568
Effective Tax Rate (%)
19.88
20.04
19.37
17.68
17.58
17.48
17.06
10.92
14.83
17.73
18.32
17
18.68
18.85
Profit Margin (%)
17.57
17.47
19.46
20.24
21.81
22.66
20.29
9.74
9.76
23.83
27.61
30.23
29.79
29.91
Working Capital
5,389
6,177
6,032
6,445
6,903
9,217
9,097
6,383
5,778
8,004
11,501
12,818
14,696
15,625
LT Debt
5,142
5,152
3,664
3,689
2,508
2,512
2,513
74
54
40
74
102
84
81
Total Equity
9,597
11,260
13,100
14,788
16,705
18,744
20,265
18,837
17,618
20,005
24,098
27,801
31,171
32,974
Return on Invested Capital (%)
17.18
17.31
19.43
19.76
20.34
19.9
16.86
5.52
6.91
25.96
30.61
28.77
24.6
23.11
Return on Capital (%)
20.41
19.95
22.25
22.21
22.13
21.48
18.04
6.06
6.82
26.8
32.3
30.35
25.73
24.44
Return on Common Equity (%)
31.99
30.1
32.34
29.11
27.41
25.23
20.36
6.47
7.03
27.59
33.1
31.06
26.29
24.95

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
22
23
22
LT Borrowings
23
23
24
LT Finance Leases
66
61
58
Preferred Equity and Hybrid Capital
1
1
1
Shares Outstanding
795
795
795
Market Capitalization
109,177
135,418
127,067

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
16,740
18,781
20,110
Cash, Cash Equivalents & STI
12,561
13,948
14,340
Accounts Receivable, Net
3,623
4,269
5,219
Inventories
301
371
322
Total Current Liabilities
3,546
4,085
4,485
Payables & Accruals
3,324
3,841
4,207
ST Debt
22
23
22
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.41%
11.01%
12.12%
Free Cash Flow
19.55%
44.99%
-16.25%
Net Income, GAAP
29.86%
71.33%
-3.38%
Sales/Revenue/Turnover
6.04%
17.79%
-1.95%
Total Cash Common Dividend
10.33%
10.4%
-3.08%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6,537
6,303
6,405
6,473
25,718
2025
6,141
6,024
6,513
6,537
25,215
2026
6,224
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.5
2.43
2.46
- -
9.78
2025
2.18
2.34
2.56
- -
- -
2026
2.06
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
3.15
2.01
- -
5.16
2025
- -
3
2
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Artirat Charukitpipat
Full Time Employees
4,506
Sector
Healthcare
Industry
Medical - Care Facilities
Address
33 Sukhumvit Soi 3 (Nana Nua) Bangkok BM Thailand 10110
IPO Date
Apr 5, 2010
CIK
0001547870
Website
bumrungrad.com
Similar Companies
NMC Health plc (NMHLY)
Krishna Institute of Medical Sciences Limited (KIMS.BO)
Topchoice Medical Corporation (600763.SS)
Unihealth Hospitals Ltd. (UNIHEALTH.NS)
Greenbrook TMS Inc. (GBNH)
Quantum Medical Transport, Inc. (DRWN)
Business
Bumrungrad Hospital Public Company Limited (BUGDF) owns and operates Bumrungrad International Hospital, Southeast Asia's largest private hospital, along with affiliated healthcare entities providing inpatient and outpatient services, specialty clinics, wellness centers, and diagnostic facilities; core offerings encompass 47 specialty centers covering allergy, arrhythmia, cardiology, oncology, orthopedics, dental care, advanced diagnostics, therapeutics, surgical services, intensive care, rehabilitation, telemedicine via Bumrungrad@Home, preventive genomics, family checkups, breast health, sports medicine, joint treatments, and innovative procedures such as hypoglossal nerve stimulation for sleep apnea and photon-counting CT imaging. The company maintains a licensed capacity of 580 beds at its flagship Bangkok facility, capable of handling over 5,500 outpatients daily, while treating more than 1.1 million patient episodes annually, including over 643,000 international cases from 180 countries, with primary revenue from hospital operations (93%), wellness services via Vitallife (4.1%), and overseas contributions like Ulaanbaatar Songdo Hospital in Mongolia (1.6%). Founded in 1980 and headquartered in Bangkok, Thailand, Bumrungrad serves premium domestic and international patients, particularly from Qatar, Myanmar, and the United States, with 65% of 2024 revenues from overseas markets; it operates subsidiaries including Vitallife Corporation Limited, Asia Global Research Ltd., Bumrungrad Myanmar Co. Ltd., Bumrungrad Health Network Co. Ltd., and Bumrungrad Mongolia LLC, plus associates such as BB Health Venture Co. Ltd. and RAKxa Venture Co. Ltd. Recent developments include the 2023 acquisition and rebranding of shares in Mongolia operations via Bumrungrad Health Network, renaming Vitallife Switzerland AG to Keyoniq Health AG in 2024 for predictive and regenerative care, adoption of photon-counting CT technology and hypoglossal nerve stimulation treatments, strong Q2 2025 financial results driven by Middle East recovery, and expansion of the Bumrungrad Health Network model through jointly operated Centers of Excellence with partner hospitals. Accredited by JCI, HA, AHA, CAP, and GHA, the company holds recognitions as a top world medical destination by Newsweek and Thailand's leading hospital.